Wellington Management Group LLP Has $72.39 Million Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN

Wellington Management Group LLP cut its holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 2.0% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 1,729,032 shares of the company’s stock after selling 36,087 shares during the quarter. Wellington Management Group LLP’s holdings in Guardian Pharmacy Services were worth $72,395,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in GRDN. Boston Partners boosted its holdings in Guardian Pharmacy Services by 418.7% in the third quarter. Boston Partners now owns 1,046,877 shares of the company’s stock worth $26,922,000 after acquiring an additional 845,048 shares in the last quarter. Jennison Associates LLC boosted its holdings in Guardian Pharmacy Services by 609.5% during the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock worth $30,986,000 after acquiring an additional 706,823 shares during the last quarter. Loomis Sayles & Co. L P purchased a new position in Guardian Pharmacy Services during the fourth quarter worth about $19,126,000. Millennium Management LLC boosted its stake in shares of Guardian Pharmacy Services by 725.2% in the 3rd quarter. Millennium Management LLC now owns 342,038 shares of the company’s stock worth $8,972,000 after buying an additional 300,587 shares during the last quarter. Finally, TimesSquare Capital Management LLC boosted its position in Guardian Pharmacy Services by 21.9% in the fourth quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company’s stock worth $31,538,000 after purchasing an additional 187,963 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research firms have weighed in on GRDN. Bank of America boosted their target price on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Weiss Ratings upgraded Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Oppenheimer boosted their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Finally, Truist Financial upped their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $43.83.

Guardian Pharmacy Services Stock Up 0.9%

Shares of NYSE GRDN opened at $39.24 on Thursday. The firm’s fifty day moving average is $39.80 and its 200 day moving average is $38.01. Guardian Pharmacy Services, Inc. has a 52 week low of $23.14 and a 52 week high of $47.02. The company has a market cap of $1.95 billion, a price-to-earnings ratio of 38.09, a PEG ratio of 2.01 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. The firm had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. Equities research analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.